ASPIRE Dermatology Landing Page

Pfizer is proud to offer the 2017 ASPIRE Dermatology Research Awards

This ASPIRE program is part of Pfizer's commitment to supporting research in inflammatory and immune-mediated diseases in Dermatology.

Mission

The mission of the ASPIRE program is to fund high quality basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases.

Background

Scientific research continues to advance our knowledge and understanding of inflammatory and immune-mediated diseases. The 2017 ASPIRE Dermatology Disease Research Awards will fund meritorious research proposals that have the potential to improve patient care.

Areas of Focus

Research areas of interest in dermatology are as follows:

  • Clinical research related to inflammatory or immune-mediated diseases in dermatology
  • Approaches to improving communication among patients and healthcare providers (e.g., enduring materials, technological advancements, or web-based teaching programs)
  • Health economic and outcomes research related to inflammatory or immune-mediated diseases in dermatology
  • Basic research in the etiology of inflammatory or immune-mediated diseases in dermatology including clarification of the intracellular immune cascade in the skin
  • Exploration of the role of PDE4 inhibition in inflammatory or immune mediated skin disease
  • Exploration of the role of PDE4 inhibition in itch
  • Use of clinical evaluation tools to document the severity of inflammatory or immune mediated skin disease and/or the impact of these conditions on quality of life or other patient reported outcomes
  • Approaches to improving adherence to topical therapy for atopic dermatitis
  • Approaches to improving management of inflammatory skin diseases (e.g. early therapy, prevention of flares, long-term maintenance, sequential treatment, bimodal therapy, etc.)
  • Research related to, but not limited to, the use of topical PDE4 inhibition in the treatment of inflammatory or immune-mediated skin disorders with an unmet therapeutic need

Available Awards

The 2017 ASPIRE Dermatology Disease Research Awards are up to a maximum of $150,000 each. Research projects are expected to complete within 2 years of study start. Up to 5 awards may be given.